Increased incidence of Mycoplasma pneumoniae infection in Norway 2011

H Blystad1, G Ånestad, D F Vestrheim

  • 1Norwegian Institute of Public Health, Oslo, Norway. hans.blystad@fhi.no

Insights

Recent Mycoplasma pneumoniae epidemics in Europe led to erythromycin shortages. Alternative antibiotics are now recommended to manage these respiratory infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Recent Mycoplasma pneumoniae epidemics reported in England, Wales, and Denmark.
  • An increase in M. pneumoniae infections observed in Norway during autumn 2011.
  • These widespread M. pneumoniae outbreaks highlight a growing public health concern.

Purpose of the Study:

  • To document the Mycoplasma pneumoniae epidemic in Norway.
  • To address the implications of the epidemic on antibiotic availability.
  • To recommend alternative treatment strategies due to erythromycin shortages.

Main Methods:

  • Epidemiological surveillance of M. pneumoniae infections.
  • Monitoring antibiotic supply chains.
  • Clinical case reviews and treatment guideline updates.

Main Results:

  • A significant increase in M. pneumoniae infections occurred in Norway in late 2011.
  • The epidemic caused a shortage of erythromycin, a primary treatment.
  • Alternative antibiotic therapies became necessary for managing M. pneumoniae.

Conclusions:

  • The M. pneumoniae epidemic necessitated a shift in treatment protocols.
  • Ensuring adequate antibiotic stocks is crucial during infectious disease outbreaks.
  • Further research into alternative treatments for M. pneumoniae is warranted.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...